Cognito Therapeutics, Inc.

Cognito is a venture-backed (Morningside Ventures) startup company translating scientific findings from MIT into therapeutic approaches for Alzheimer’s disease and other neurodegenerative conditions. We are a fast-moving, highly motivated team of people with the ambitious goal of helping the millions of Alzheimer’s disease patients and caregivers around the world. With our patented gamma stimulation technology, we are committed to developing non-invasive device-based therapies. Developing this unique platform requires expertise across a range of fields.